Biosimilars: what is NHS England's policy?

NHS England is implementing a policy designed to encourage the use of good value biosimilars as established biologics lose their patent protection.

This briefing explains what is being asked of commissioners and providers, and how the policy is expected to work.

Click here to view the fastfact.